B

Workshops and Roundtable: Agendas and Participants

INSTITUTE OF MEDICINE

NATIONAL ACADEMY OF SCIENCES

Committee on Community-Based Drug Treatment

Roundtable on Community-Based Drug Treatment:

The Need for Partnership Among Providers, Policymakers, and Researchers

Tuesday, July 29, 1997

Lecture Room, National Academy of Sciences

2101 Constitution Avenue, N.W., Washington, D.C.

WORKSHOP AGENDA

10:00 a.m

Welcome and Introductions—Overview of Objectives for the Day and Review of Open Meetings Policy*

Merwyn R. Greenlick, Committee Chair

*  

The meeting is being held to gather information to help the committee conduct its study. This committee will examine the information and material obtained during this, and other public meetings, in an effort to inform its work. Although opinions may be stated and lively discussion may ensue, no conclusions are being drawn at this time. In fact, the committee will deliberate thoroughly over the next few months before writing its draft report. Moreover, once the draft report is written, it must go through a rigorous review by experts who are anonymous to the committee, and the committee then must respond to this review with appropriate revisions that adequately satisfy the Academy's Report Review Committee and the chair of the NRC before it is considered an NRC report. Therefore, observers who draw conclusions about the committee's work based on today's discussions will be doing so prematurely.

Furthermore, individual committee members often engage in discussion and questioning for the specific purpose of probing an issue and sharpening an argument. The comments of any given committee member may not necessarily reflect the position he or she may actually hold on the subject under discussion, to say nothing of that person's future position as it may evolve in the course of the project. Any inference about an individual's position regarding findings or recommendations in the final report are therefore also premature.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 125
B Workshops and Roundtable: Agendas and Participants INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES Committee on Community-Based Drug Treatment Roundtable on Community-Based Drug Treatment: The Need for Partnership Among Providers, Policymakers, and Researchers Tuesday, July 29, 1997 Lecture Room, National Academy of Sciences 2101 Constitution Avenue, N.W., Washington, D.C. WORKSHOP AGENDA 10:00 a.m Welcome and Introductions—Overview of Objectives for the Day and Review of Open Meetings Policy* Merwyn R. Greenlick, Committee Chair *   The meeting is being held to gather information to help the committee conduct its study. This committee will examine the information and material obtained during this, and other public meetings, in an effort to inform its work. Although opinions may be stated and lively discussion may ensue, no conclusions are being drawn at this time. In fact, the committee will deliberate thoroughly over the next few months before writing its draft report. Moreover, once the draft report is written, it must go through a rigorous review by experts who are anonymous to the committee, and the committee then must respond to this review with appropriate revisions that adequately satisfy the Academy's Report Review Committee and the chair of the NRC before it is considered an NRC report. Therefore, observers who draw conclusions about the committee's work based on today's discussions will be doing so prematurely. Furthermore, individual committee members often engage in discussion and questioning for the specific purpose of probing an issue and sharpening an argument. The comments of any given committee member may not necessarily reflect the position he or she may actually hold on the subject under discussion, to say nothing of that person's future position as it may evolve in the course of the project. Any inference about an individual's position regarding findings or recommendations in the final report are therefore also premature.

OCR for page 125
10:25 Provider Panelists—Robert Fullilove, Panel Host Arthur Schut,* President, Iowa Substance Abuse Program Director's Association Anne Tafe,* Executive Director, Massachusetts Drug Abuse Association Robert Kahn,* President, California Organization of Methadone Providers Robert G. Newman,* President and CEO, Beth Israel Medical Center Selbert Wood,* President and CEO, STEP ONE, Inc. Gaurdia Banister, Director of Behavioral Health Services, Seton House Beny J. Primm, Executive Director, Addiction Research and Treatment Corporation Mark Publickler, Chief of Addiction Medicine, Kaiser Permanente Mid-Atlantic Region Discussion: Question and Answer 11:35 Policy Panelists—Steven Mirin, Panel Host Marsha Lillie-Blanton, Associate Director, U.S. General Accounting Office Rosalind Brannigan, Vice President, Drug Strategies June Osborn, President, Josiah Macy Jr. Foundation Hernando Posada Assistant Director, Ohio Department of Alcohol and Drug Addiction Services Richard Suchinsky, Addictive Disorders, Department of Veterans Affairs Discussion: Question and Answer 12:45 p.m. LUNCH—Provided for panelists and registered observers outside the Lecture Room 1:30 Research Panelists—James Sorenson, Panel Host Lisa Borg, Rockefeller University Alec Cristoff, Alexandria, VA Jeffrey Hoffman, President and CEO, Danya International, Inc. *   Members, National Coalition of State Alcohol and Drug Treatment and Prevention Associations.

OCR for page 125
  David Nurco, Social Research Center, University of Maryland at Baltimore Harold Shinitzky, Department of Pediatrics, Johns Hopkins University School of Medicine Maxine Stitzer, Principal Investigator, Behavioral Biology Research Center, Johns Hopkins University School of Medicine George Woody, Department of Psychiatry, University of Pennsylvania Discussion: Question and Answer 2:40 General Discussion 3:30 Summary Recommendations and Wrap-up 4:00-5:00 RECEPTION for Roundtable participants in the Rotunda LIST OF TOPICS TO BE ADDRESSED BY PARTICIPANTS Perspectives of providers and policymakers on the value of participating in research. Examples of successful and unsuccessful efforts to do collaborative research. Examples of successful and unsuccessful efforts to implement new research findings. Examples of successful and unsuccessful efforts to incorporate new information into management practice and service delivery. Availability of funding for research in a community treatment setting. Incentives and disincentives for doing research and implementing new treatments in community treatment settings. Experiences with successful models for research/practice interaction in other fields. Changes in the current environment that impact community-based treatment organizations. Suggestions for ways to ''market" research findings and shorten time from "bench to trench." What policymakers need from researchers to support implementation of research findings.

OCR for page 125
PARTICIPANT LIST Gaurdia E. Banister Director of Behavioral Health Services Seton House Washington, DC Lisa Borg Laboratory of the Biology of Addictive Diseases Rockefeller University New York, NY Joseph V. Brady Professor of Behavioral Biology The Johns Hopkins University School of Medicine Baltimore, MD Rosalind Brannigan Vice President Drug Strategies Washington, DC Mady Chalk Director, Managed Care Initiatives Center for Substance Abuse Treatment Rockville, MD Alec Christoff Alexandria, VA Dorynne Czechowicz Division of Clinical and Services Research National Institute on Drug Abuse Rockville, MD Deborah Haller Associate Chair Division of Substance Abuse Medicine Medical College of Virginia Virginia Commonwealth University Richmond, VA Vincent G. Hodge Employee Assistance Consultant COPE, Inc. Washington, DC Jeffrey A. Hoffman President and CEO Danya International, Inc. Silver Spring, MD Robin Huffman Regional Director of Business Development/Charter Behavioral North Carolina Association for Behavioral Health Care Greensboro, NC Robert B. Kahn President, California Organization of Methadone Providers San Diego, CA Andrea Kamargo Health Services Quality and Public Health Issues U.S. General Accounting Office Washington, DC Linda Kaplan Executive Director The National Association of Alcoholism and Drug Abuse Counselors Arlington, VA

OCR for page 125
Marsha Lillie-Blanton Associate Director Health Services Quality and Public Health Issues U.S. General Accounting Office Washington, DC James O. McClyde Assistant Director Health Services Quality and Public Health Issues U.S. General Accounting Office Washington, DC Robert G. Newman President and CEO Beth Israel Medical Center New York, NY David N. Nurco Research Professor Department of Psychiatry University of Maryland at Baltimore Baltimore, MD June Osborn President Josiah Macy Jr. Foundation New York, NY Nina Peyser Executive Director Grants Management and Research Support Beth Israel Medical Center New York, NY Harold Alan Pincus Deputy Medical Director and Director, Office of Research American Psychiatric Association Washington, DC Hernando J. Posada Assistant Director Ohio Department of Alcohol and Drug Addiction Services Columbus, OH Beny J. Primm Executive Director Addiction Research and Treatment Corporation Brooklyn, NY Mark Publicker Chief of Addiction Medicine Kaiser Permanente Mid-Atlantic Region Merrifield, VA Gwen Rubinstein Deputy Director of National Policy Legal Action Center Washington, DC Arthur Schut President, Iowa Substance Abuse Program Directors' Association c/o Mid-Eastern Council on Chemical Abuse Iowa City, IA Harold Shinitzky Psychology Instructor Department of Pediatrics Johns Hopkins University School of Medicine Baltimore, MD

OCR for page 125
Maxine L. Stitzer Professor of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore, MD Richard T. Suchinsky Associate Chief for Addictive Disorders Department of Veterans Affairs Washington, DC Anne Tafe Executive Director Massachusetts Alcoholism and Drug Abuse Association Boston, MA Selbert M. Wood, Jr. President and CEO STEP ONE, Inc. Winston-Salem, NC

OCR for page 125
INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES Committee on Committee-Based Drug Treatment Workshop on Community-Based Drug Treatment: The Need for Partnership Among Providers, Policymakers, and Researchers September 8, 1997 Scholes Hall—Roberts Room University of New Mexico Campus Albuquerque, NM WORKSHOP AGENDA 10:30 a.m. Welcome and Introductions Merwyn R. Greenlick, Committee Chair Philip A. May, Director, CASAA   Review of IOM Open Meeting Policy Overview of Objectives for the Day 11:00 Overview of the community-based drug abuse treatment system in New Mexico, including diverse cultures and special populations (e.g., community corrections, adolescents, pregnant women) 12:30 p.m. Break to pick up box lunches 12:45 Examples of research carried out in community-based programs with providers as partners from the beginning 1:30 Examples of successes and failures in dissemination of research findings and utilization of relevant clinical experience in the design of research 2:15 Perspectives of community providers on the pros and cons of participating in research. What research is needed and why? 3:00 Wrap-up and Summary 3:30 Adjourn workshop

OCR for page 125
PARTICIPANT LIST Patrick Abbott Center on Alcoholism, Substance Abuse and Addiction Albuquerque, NM Lynn Brady Behavioral Health Services Division Department of Health Santa Fe, NM Robert Fiorentine Drug Abuse Research Center University of California at Los Angeles Los Angeles, CA Jan Gossage Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM Valerie L. Graber Student Support Services Albuquerque, NM Linda Grant Washington Association of Alcoholism and Addictions Programs Kirkland, WA Brian Greenberg Walden House San Francisco, CA James Hall Sante Fe County District Court Sante Fe, NM Constance Horgan Institute for Health Policy Brandeis University Waltham, MA Arnold Kaluzny University of North Carolina School of Public Health Cecil G. Sheps Center Chapel Hill, NC Michael W. Kirby Arapahoe House, Inc. Thorton, CO Patricia Knox The Center for Alcohol and Drug Treatment Wenatchee, WA Walter Lang New Mexico State Probation and Parole Albuquerque, NM Francesca G. Lanier Grant Management and Accountability Albuquerque Public Schools Albuquerque, NM Carol Leonard The Navajo Nation Dine'Center for Substance Abuse Treatment Window Rock, AZ Chilo Madrid Aliviane, Inc. El Paso, TX

OCR for page 125
Philip A. May University of New Mexico Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM Robert Meyers Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM Rick Miera Bernalillo County Juvenile Detention Center and New Mexico State Legislature Albuquerque, NM Joseph "Bo" Miller Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM Josi Noyes EAP Public Service Co. of New Mexico (Retired) Sandia Park, NM Carole Otero Albuquerque Metropolitan Central Intake Albuquerque, NM Michael M. Passi Family and Community Services Department Albuquerque, NM Robert Phillips Eastern New Mexico University-Roswell Roswell, NM Fernando Rodriquez Aliviane, Inc. El Paso, TX Everett Rogers Department of Communication and Journalism University of New Mexico Albuquerque, NM Mary E. Steil City of Albuquerque, Family and Community Services Department Albuquerque, NM Scott Wallace San Juan County DWI Treatment Facility Farmington, NM Verner Westerberg Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM W. Gill Woodall Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM Carolina E. Yahne Center on Alcoholism, Substance Abuse and Addictions Albuquerque, NM

OCR for page 125
INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES Committee on Committee-Based Drug Treatment Roundtable Discussion with Local Providers October 23, 1997 Seton House at Providence Hospital Washington, DC PARTICIPANT LIST Darryl Colbert Program Administrator Substance Abuse Network Catholic Charities Washington, DC Diane Lewis Consultant Marshall Heights Community Development Organization Washington, DC Arthur Melvin Clinic Manager Umoja Treatment Center Washington, DC Betty Palmer Nurse Manager Seton House at Providence Hospital Washington, DC Gale Saler Executive Deputy Director Second Genesis Bethesda, MD Steve Wright Center Manager Addiction, Prevention, and Recovery Administration Washington, DC Ronald D. Wynne Director Washington Assessment and Therapy Services Washington, DC